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Summary.-Certain strains of Salmonella typhimurium and Escherichia coli, particu-
larly those which are very sensitive to u.v. light, are killed when incubated with
rat liver mixed function oxidases and aflatoxin B1. UvrA or recA strains of E.
coli are more susceptible than the wild-type strain, while the double mutant uvrA
recA is the most sensitive strain yet tested. The aflatoxin B1 metabolite is also
able to induce reverse mutations in 2 histidine auxotrophic strains of S. typhi-
murium, one strain of which is reverted specifically by frame shift mutagens and the
other by agents inducing base pair substitutions.
Pretreatment of rats with either 3-methylcholanthrene or benzo(a)pyrene, both
inducers of liver microsomal mixed function oxidases, did not alter the amount of
lethal aflatoxin B1 metabolite formed, whereas an increase was observed after
phenobarbitone pretreatment. Addition of the nucleophiles methionine, cysteine,
glutathione, sodium thiosulphate or sodium sulphide, or the epoxide hydrase inhibi-
tor, cyclohexene oxide to the toxicity assay medium did not alter bacterial killing
by the aflatoxin B1 metabolite. 2,3-Dimercaptopropanol had some protective
action.
Toxic metabolites were also formed when 5-methoxysterigmatocystin, 0-
methylsterigmatocystin, parasiticol or versicolorin A, but not vericolorin B, were
incubated with mixed function oxidases. The relationship between the metabolite
of aflatoxin B1 lethal to bacteria and that which initiates liver cancer is discussed.
AFLATOXIN B a metabolite of the
mould Aspergillus flaJnus, has been found
as a contaminant of human foods (Shank,
Wogan and Gibson, 1972). The com-
pound is the most potent liver carcinogen
known for the rat (Wogan and Newberne,
1967) and is suspected of being a primary
cause of human liver cancer in certain
areas, particularly in Africa (IARC, 1972).
Little is known about the mechanism
of tumour initiation by aflatoxin B1
compared with other chemical carcino-
gens, although there have been manv
reports on the biochemical and patholo-
gical alterations found after aflatoxin
B1 administration to animals (Goldblatt,
1969). Recent work on other chemical
carcinogens suggests that many of them
must be metabolized before they can
initiate cancer (Miller, 1970; Magee and
Swann, 1969). These metabolic processes
are often catalysed by liver microsomal
mixed function oxidases and yield reac-
tive, short-lived intermediates which in-
teract with tissue components to initiate
the cancer process. Some of these reac-
tive molecules can also induce mutations
in bacteria although the parent com-
pounds are non-mutagenic. For example,
dimethylnitrosamine is non-mutagenic
when applied directly to bacteria but
can be converted to a mutagenic com-
pound by liver mixed function oxidases
(Mailing, 1971).ACTWATION OF AFLATOXI:N B1
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FIG. 1. The structure of aflatoxin B1 and related compounds used in the microsomal activation assay.
Aflatoxm B1 has been shown to be
mutagenic for Drosophila (Lamb and
Lilly, 1971), Neurospora (Ong and de
Serres, 1972) and bacterial transforming
DNX (Maher and Summers, 1970). The
compound will also transform mammalian
liver cells in tissue culture (Toyoshima et
al., 1970). WArhen aflatoxuin B1 was tested
in a microsomal activation assav in
vitro, it was shown to be converted by
liver mixed function oxidases to a reactive
metabolite toxic to 2 strains of S. typhi-
murium (Garner et al., 1971). Other
compounds structurallv similar. to afla-
toxin B1 were also active but only if
there was an isolated double bond at the
2, 3 position (see Fig. 1) (Garner, Mtiller
and Miller, 1972). The metabolite formed
was labile, reacted with cellular macro-
molecules and attacked DNAX preferen-
tiallv. Studies with polynucleotides in-
dicated that purine bases, especiallv
guanine, were attacked (Garner, 1973a).
Further work on the genetic determinants
of bacterial sensitivitv is reported in this
paper, together with the activity of some
aflatoxin-analogues not previouslv tested
in the toxicitv assav.
MATERIALS AND METHODS
Animalsandtiuepreparatian.-250-300g
male Wistar rats (A. Tuck and Son,
Rayleigh, Essex) were fed diet 41B (Bruce
and Parkes, 1956) ad libitum. For induction
studies rats were injected intraperitoneally
with either 3 dailv doses of 3-methvl-
cholanthrene (40 mg/kg body weight as a
40 mg/ml suspension in corn oil) or a single
dose of benzo(a)pyrene (20 mg/kg as a
20 mg/ml suspension in corn oil) 24 hours
before killing. Control animals received
equal volumes of corn oil alone. Pheno-
barbitone pretreated animals were given a
1 mg/mil solution of sodium phenobarbitone
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as drinking water for at least 1 week before
killing (Marshall and McLean. 1969).
Livers for use in the microsomal activa-
tion assay were removed and subfractionated
as previously described (Garner et al..
1972).
C(hemirals.-Aflatoxin B1. B2 and sterig-
matocystin were purchased from Makor
Chemicals Ltd., Jerusalem. Israel. Para-
siticol was kindly provided through Dr E.
Lillehoj. Northern Regional Research Labora-
tories. U.S. Department of Agriculture.
Peoria. Ill., 61604. U.S.A.. and 0-methyl-
sterigmatocystin, 5-methoxysterigmatocystin
and versicolorins A and B by Dr J. S. E.
Holker, Department of Organic Chemistrv,
University of Liverpool. Methionine, gluta-
thione. cysteine, sodium thiosulphate and
sodium sulphide were purchased from British
Drug Houses. Poole. Dorset. Cyclohexene
oxide and 2.3-dimercaptopropanol were from
Koch-Light. Colnbrook. Bucks.
Bacterial strains.-All strains of Sal-
monella typhimurium were obtained from
Professor B. N. Ames. Department of Bio-
chemistry, University of California at Berke-
ley, Calif. 94720. Details of their genetic
composition are to be found in a publication
by Ames (1971). Escherichia coli strains
AB 1157, AB 2463. AB 1886 and AB 2480
were donated by Dr D. J. G. Davies. Uni-
versitv of Bath. Details of mutations in
the AB series are to be found in a publication
bv Tvrell, Moss and Davies (1972).
Procedure for the mikrosomal activation
assay.-Overnight nutrient broth cultures
of the bacterial strains were harvested by
centrifugation and resuspended in 0.9% w/v
NaCl. Approximatelv 34-5 x 108 bacteria
of the strain to be used was added to the
tissue preparation and incubated with afla-
toxin B1 or the compound under test as
previouslv described (Garner et al.. 1972).
Survivors for the E. coli strains were deter-
mined bv serial dilution and plating out on
minimal Davis agar plates supplemented
with the necessarv amino acids and vitamins.
For the S. typhimurium, strains reverse
mutations from histidine auxotrophy to
prototrophy were assaved by plating on to
minimal Davis agar supplemented with a
trace (0-1 1imol) of histidine and 0.1 gLmol
biotin. Numbers of survivors were deter-
mined by serial dilution and plating on to
minimal Davis agar plates containing 5 Mmol
histidine and 0-1 1imol biotin.
To test that the reverse mutations in S.
typhimurium were not due to selection of
bacteria resistant to the aflatoxin B1 meta-
bolite but genuine mutations, a number of
mutant colonies obtained after exposure to
the aflatoxin B1 metabolite were picked off
plates and streaked on minimal Davis agar
plates containing 0-1 ymol biotin. Indivi-
dual colonies were isolated from these plates.
inoculated into nutrient broth. grown up
overnight and tested for sensitivity to the
lethal effect of the aflatoxin B1 metabolite
as above.
All agar plates in the above assays were
incubated at 37°C for 48 hours before
counting numbers of mutants and survivors.
RESULTS
U'se of ultra-violet light sensitive strains
of either E. coli or S. tvphimurium in the
toxicity assay
Previous work has shown that 2
strains ofS. typhimurium, with a deletion
including the uvrB gene are killed when
incubated with liver mixed function
oxidases and aflatoxin B1 (Gamer et
al., 1971). Neither aflatoxin B1 nor the
liver preparation alone were toxic. Both
of these strains, as with all urrA, B or
C mutants, are more sensitive than the
wild-tvpe strains to a variety of chemical
mutagens because thev are deficient in
one of the functions (in this case the
uvrB gene product) required to repair
UV or mutagen damaged DNA (Ames,
1971). However, it was not possible to
ascribe sensitivitv to the aflatoxin B1
metabolite solelv to the absence of this
DNA repair function since other adjacent
genes were also deleted (gal, chl, hut,
bioA). In preliminarv experiments using
E. coli strains with point mutations rather
than theS. typhimurium strainspreviously
used in the toxicity assay, it was found
that it was onlv the absence of the uvrB
gene product which increased sensitivity
to the aflatoxin B1 metabolite markedlv.
In the S. typhimurium series the presence
or absence of the galactose gene mutation
also affected sensitivity galt strains being
less sensitive than gal strains (data not
shown).
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Recombination deficient (rec) mutants
are also sensitive to u.v. light through
their deficiencv in post-replication repair
(Howard-Flanders, 1968). In a series of
E. coli mutants, carr-ing uvrA and/or
recA, the double mutant uvrA recA,
which is both recombination deficient and
unable to excise thv-mine dimers, is the
most sensitive strain so far tested. This
parallels the sensitivity of this strain
to u.v. light (Table I). No survivors
were found at a 104 dilution for strain
AB 2480 when incubated with aflatoxin
B1 and 40 mg liver post-mitochondrial
fraction.
TABLE I
writh I
Light
Assay
Strain
AB 1157
AB 2463
AB 1886
-B 2480
I. Use of E. coli K12 Strains
rTarying Sensitivity to U'ltraviolet
in the Microsonul Activation
Mutation
None
recA
utrA
urrA. recA
Surviv-al [no. Viable bacteria
(treated)/no. viable bacteria
(control) x 100]
Amount of liver
K
5 mg 40 mg
106 61
98 48
62 16
08 >001
Aliquots of pooled liver postmitochondrial
fraction from 3 rats were incubated with 60 ,umol/l
aflatoxin B1 and the bacterial strain under test for
20 min at 37 C. Each liver sample was assayed in
duplicate at 4 levels from 5 to 40 mg liver equi-
valents. Only the data from these two levels are
presented in the table. Each strain was tested
independently.
None of the bacterial strains used in
this work were killed by aflatoxin B1
alone at the concentrations used or by
the liver preparation. Heat denaturing
the liver preparation abolished all killing
activity.
Induction of reverse mutations after expo-
sure to the aflatoxin B1 metaboite
The strains of S. typhimurium used
in this work were constructed to charac-
terize particular classes of chemical muta-
gens (Ames, 1971). They are all histidine
auxotrophs, that is, they have an absolute
requirement for histidine and are reverted
to the wild type by agents causing either
base pair substitutions or frame shift
mutations. Strain TA 1530 is reverted
by alkylating agents, such as the nitrogen
mustards, but not frame shift mutagens,
whereas strain TA 1531 is reverted by
frame shift mutagens, but not agents
causing base pair substitutions. Both
these strains are mutated by the afla-
toxin B1 metabolite (Table II), the
number of mutants obtained being de-
pendent on the amount of reactive afla-
toxin B1 metabolite produced. Strains
his G46 and his C207 which are resistant
to the toxic effects of the metabolite are
not mutated by it.
Eight individual mutant colonies of
each sensitive S. typhimurium strain ob-
tained after exposure to the aflatoxin B1
metabolite were isolated, grown innutrient
broth and used again to check their
sensitivitv to the lethal effects of the
aflatoxin B1 metabolite in the micro-
somal activation. No difference in sensi-
tivity was found between these mutant
bacteria and the histidine auxotrophs,
showing that a population resistant to
the aflatoxin B1 metabolite had not been
selected.
Effect of addition of nucleophiles, cyclo-
hexene oxide or incubation at 30°C on
killing of S. typhimurium when incubated
ivth aflatoxin B1 and liver mixed function
oxidases
None ofthe following: cysteine, methi-
onine, glutathione, sodium thiosulphate,
sodium sulphide, all nucleophiles, or
cyclohexene oxide, an epoxide hydrase
inhibitor, when added to the toxicitv
assay medium at 1 mmol/l concentration,
affected the number of S. typhimurium
TA 1530 killed. The assav contained
12-5 mg fresh liver equivalents of micro-
somes, an NADPH2 generating svstem,
60 ftmol/l aflatoxin B1, the inhibitor and
S. typhimurium TA1530. 1 mmol[l 2,3-
dimercaptopropanol inhibited killing by
three-fold (42%o survivors in the presence
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TABLE II.-Induction of Reverse iutations in 2 Strains of S. tvphimurium After
Incubation in the Liver Microsomal Activation Assay with Aftatoxin B1
No. viable bacteria (treated/
Amount of liver no. viable bacteria (control) Histidine revertants/
Strain (mg) x 100 10' survivors
TA1530+aflatoxin B1 10 38 13-2
20 1 107-9
-aflatoxin B1 10 (100) 1-3
TA 1531-aflatoxin B1 10 12 21-4
20 2 243-9
-aflatoxin B1 10 (100) 1-7
Replicate flasks containing the above amounts of liver post-mitochondrial fraction were incubated at
37 C for 20 min with 60 umol/l aflatoxin B1 and the bacterial strain under test. Numbers of histidine
revertants and survivors were determined.
of dimercaptopropanol, 15% in its ab-
sence). Incubation of the microsomal
activation assay with aflatoxin B1 and S.
typhimurium TA 1530 at 30TC, a tem-
perature at which the action of epoxide
hydrase, an epoxide degradative enzvme,
is said to be inhibited (Grover, Hewer
and Sims, 1971) showed a decrease in the
number ofbacteria killed. Ifthe hvdrase
is responsible for degrading the mutagenic
aflatoxin B1 metabolite; then one would
expect an increase in mutagen concen-
TABLE Ill.-The Effect of Pretreating
Rats with Either 3-Methylcholanthrene
or Ph-enobarbitone on Liver Activity in
the Jlicrosomal Activation Assay
Survival [no. viable
bacteria (treated)/no.
viable bacteria (control)
x 100]
Amount of liver
Experi-
Pretreatment ment 0-5mg 2-0mg
3-methyl- 1 18 5
cholanthrene
Corn oil
Phenobarbitone
Control
2
28
3
8
5
0-04
2
Rats were either given 3 daily injections of
40 mg/k-g 3-methylcholanthrene dissolved in corn
oil or a 1 mg/ml solution of sodium phenobarbitone
as drinking water for at least 7 days. For com-
parison with 3-methylcholanthrene treated rats,
control rats received an equivalent volume of corn
oil. Aliquots of pooled postmitochondrial fraction
from 3 rats were incubated in the usual assay
medium with E. coli AB 2480 and 60 pmol/l afla-
toxin B1. Each liver sample was assayed in
duplicate at 4 levels from 0 5 to 4 - 0 mg liver
equivalents. Only data for 0 5 and 2-0 mg liver
equivalents are presented in the table. A different
subculture of bacteria was used for each experiment.
tration because the activity of the
hydrase is inhibited. This was not the
case, there presumably being less mutagen
formed at this temperature and conse-
quentlv less killing.
Effect of pretreatment with inducers of
liver mixed function oxidases on the pro-
duction of the toxic aflatoxin B1 metabolite
Pretreatment of rats with polvcycic
hvdrocarbons did not alter the amount
of the toxic aflatoxin B1 metabolite
formed by the liver (see Table III).
Benzo(a)pyrene was tested as well as
3-methylcholanthrene and found also to
have no effect (data not presented).
Both these agents induce microsomal
polycyclic hydrocarbon epoxidase (Sims,
1970). The other class of inducing agent
for liver mixed function oxidases is
typified by phenobarbitone. Pretreat-
ment with this compound greatlv
increased production of the reactive
aflatoxin B1 metabolite (Table IV).
Comparison of activities of a number of
compounds related to aflatoxin in the
microsomal activation assay with E. coli
AB 2480
A number of compounds not pre-
viously tested in the bacterial assay were
toxic when incubated with liver mixed
function oxidases (Table IV). Parasiticol
and aflatoxin B2 are produced bv Asper-
gillus flavus, sterigmatocystin, 0-methvl-
sterigmatoevstin, 5-methoxysterigmato-
cystin and the versicolorins bv Asper-
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TABLE IJ.-Comparison of Various Bis-
furan compounds in the Mlicrosomal
Activation Assay with E. coli AB 2480
Survival [no. Viable bacteria
(treated)/no. viable bacteria
(control) x 100] with the
following toxin
concentrations
Compound
Aflatoxin B
Parasiticol
Sterigmatocvstin
O-Methylsterigrnato-
cvstin
5-Methoxvsterigmnato-
cvstiM
Versicolor'm A
Versicolorin B
Aflatoxin B.
2 ,umolI 5 ,umol l
0-3 0-04
3 03
5 0-3
12 3
18
80
105
124
6
66
96
61
Flasks containing 250 mg fresh liver equivalents
of pooled postmitochondrial fraction from 3 rats
were incubated with either 2 or 5 jumol/l of the
compound and E. coli AB 2480 for 20 min at
37 C in a 3 ml volume. Each compound was
tested independently.
gillus versicolor. Except for aflatoxin B2,
only the compounds which had a vinvl
ether grouping were active, a finding in
agreement with our previous results.
Reasons for the activity of aflatoxin B2
are discussed later. None of the com-
pounds at the concentrations used in
the host mediated assay were themselves
toxic, and all toxic activity was lost by
heat denaturing the liver preparation.
DISCUSSION
Increasing knowledge ofthe chemicallv
reactive intermediates formed by meta-
bolism in the host animal suggest that
for many classes of chemical carcinogens
active electrophilic derivatives are formed
from the parent compounds. These inter-
mediates have been shown to be muta-
genic in a number of cases, e.g. acetyl-
aminofluorene derivatives (Ames et al.,
1972); epoxides of some polycyclic hvdro-
carbons (Ames, Sims and Grover, 1971);
dialkylnitrosamine derivatives (Gabridge
and Legator, 1969).
Thus induction of mutations in bac-
teria may provide a rapid screening
method for detecting electrophilic ultimate
carcinogens. However, most bacteria are
often unable to carry out the same
activating steps as mammalian cells and
so an assay has been developed which
utilizes mammalian cell enzymes to acti-
vate the compound and microorganisms
to detect these activated molecules (Gab-
ridge and Legator, 1969). Using an in
ritro modification of this technique, it
has been shown previouslv that aflatoxin
B1 can be converted bv liver mixed
function oxidases to a reactive metabolite
which can (1) kill two strains of S.
typhimuriunm and (2) bind to cellular
macromolecules.
The sensitive S. typhimurium strains
had a number ofgene deficiencies ofwhich
the urrB gene was probablv the most
important. This gene controls one of
the functions responsible for removing
lesions in the bacterial DNA.
However, it was not possible to show
conclusivelv that sensitivitv was depen-
dent solelv on the absence of this gene
because neighbouring genes were also
deleted. From the data presented with
the E. coli strains it is possible to state
definitely that susceptibility is dependent
on the inability to repair DNA damaged
bv the aflatoxin B1 metabolite, and that
the inactivation is due to attack of DNA,
by the metabolite, since the only dif-
ference between these strains is in their
excision-repair abilitv. In the S. typhi-
murium series the composition of the
bacterial cell wall has some influence on
sensitivity since gal strains are more
sensitive than gal+ strains. A similar
observation has been noted bv other
workers, probablv because of an increased
permeability ofgal strains to the mutagens
tested due to an altered lipopolysac-
charide in the cell wall (Ames et al.,
1971; Ames, Lee and Durston, 1973).
Further evidence that the reactive
aflatoxin Bi metabolite attacks bacterial
DNA is shown by the induction of
reverse mutations in the 2 sensitive S.
typhimurium strains. This is the first
demonstration that the liver microsomal
metabolite of aflatoxin B1 is not only
toxic but mutagenic. It is surprising
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that both strains of S. typhimurium are
mutated since the two strains are said
to be mutated by different classes of
mutagen, TA 1530 by agents causing
base pair substitutions and TA 1531 by
frame shift mutagens. Probably the
metabolite can both intercalate in the
bacterial DNA to reverse the original
frame shift mutation and alkvlate bases
(guanine?) to cause a base pair substitu-
tion. The intercalation may be facili-
tated by the large planar shape of the
aflatoxin molecule, the reactive grouping
at the vinvl ether end of the molecule
generated by metabolism then attack-
ing a nucleophilic centre in the DNA.
Although previous data have shown
that the aflatoxin B1 metabolite is a
reactive, labile molecule it was not pos-
sible to identifv it. None of the known
metabolites of aflatoxin B1 were toxic
to the bacteria. On the basis of structure
actixitv studies with a number of afla-
toxin congeners it was proposed that the
reactive metabolite may be activated at
the 2, 3 double bond and might possibly
be 2,3-epoxvaflatoxin B1. The tests using
some other bisfuranoid compounds con-
firm that the vinyl ether grouping is
essential for activity. The only excep-
tion to this is aflatoxin B2. Although
one cannot rule out the possibility that
this was contaminated with trace amounts
of aflatoxin B1 (thin layer chromato-
graphy in CHC13/methanol (97 : 3) showed
aflatoxin B1 to have an Rf value of
0 90 whereas aflatoxin B2 had an Rf of
0-77 with no visible contamination with
aflatoxin B1), it could be that there are
dehvdrogenases in the liver able to
convert aflatoxin B2 to aflatoxin B1,
as suggested by other workers (Wogan,
Edwards and Newberne, 1971).
The metabolite appears not to be
attacked by the type of nucleophiles
which have shown reactivity towards the
epoxides of polcycvic hvdrocarbons.
The only nucleophile which had any
inhibit,orv action in the microsomal acti-
vation assav was 2.3-dimercaptopropanol.
The inhibitorv action of 2.3-dimercapto-
propanol may be because this compound
is readily soluble in the microsomal mem-
branes and is able to attack the toxic
metabolite almost immediately it is
formed. The effect ofdimercaptopropanol
does not appear to be due to an inhibition
of aflatoxin metabolism as experiments
using microsomes, dimercaptopropanol
and 14C aflatoxin B1 in ritro show no
alteration in the amount of aflatoxin B1
metabolized (Garner, unpublished). One
can conclude, therefore, that the metabo-
lite is reactive and that its formation is
dependent on the vinyl ether group.
Recent work has provided strong chemical
evidence for the formation of 2,3-epoxy
aflatoxin B1 during microsomal meta-
bolism: this may be the lethal and
mutagenic metabolite (Garner, 1973b).
On the basis of their studies other workers
have also suggested that aflatoxin B1 may
be converted to an active metabolite
(Goodall and Butler, 1969: Edwards and
Wogan, 1970 PattersonandRoberts, 1970).
There is now good evidence that a
correlation exists between compounds
that induce mutations in bacteria and
those which are carcinogenic (Miller and
Miller, 1971). It would be surprising
if the aflatoxin B1 metabolite(s) which
induces mutations in bacteria is in no
wav related to that which initiates cancer
in animals. Studies with aflatoxin and
related compounds clearly show the poten-
tial of these short-term tests using micro-
organisms to detect activated metabolites.
Of the compounds mentioned in this
report, a number have not been tested
for carcinogenicity (parasiticol, 0-methyl
sterigmatocystin, 5-methoxy sterigmato-
cystin and the versicolorins) although
they may be ingested by man. It is
therefore essential to look at these com-
pounds in much more detail to evaluate
any potential hazard to man.
This work was supported by a grant
from the Yorkshire Council of the Cancer
Research Campaign. We would like
to thank Dr S. Baumberg for helpful
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